Cipla Share Price Falls Over 2% After Q1 FY27 Earnings Results: Total Income Up 1.6% YoY

On July 23, 2026, Cipla Limited reported its unaudited consolidated financial results for the quarter ending June 30, 2026, as per the exchange filings.  

The company reported total incomeof ₹7,330.18 crore and net profit of ₹785.55 crore for the quarter ending June 30, 2026. 

Cipla Q1 FY27 Earnings Results  

In the June 2026 quarter, Cipla's total income reached ₹7,330.18 crore, marking a 1.6% YoY increase from ₹7,216.03 crore.  

This also reflects a 9.6% quarter-on-quarter (QoQ) growth from ₹6,689.36 crore in the March 2026 quarter.  

However, the net profit (PAT) for the June 2026 quarter decreased by 39.2% YoY to ₹785.55 crore, down from ₹1,291.61 crore in the same period last year.  

Despite this drop, the net profit showed a 44.8% QoQ increase from ₹542.51 crore in the March 2026 quarter. 

Annual Financial Performance for FY26 

For the financial year 2026, Cipla's total income was reported at ₹29,044.60 crore. The net profit for the year stood at ₹3,861.74 crore. These figures provide a comprehensive view of the company's financial performance over the year, highlighting both income and profitability metrics. 

Read More: IndusInd Bank Share Price Falls Over 5% on July 23, 2026, After Q1 FY27 Results; Net Profit Jumps 72% YoY! 

Expense Analysis and Margin Pressures 

Operational expenditures grew moderately across key segments, impacting overall profit margins. Employee benefit expenses expanded to ₹1,497.41 crore, up from ₹1,312.30 crore year-on-year.  

Concurrently, other operating expenses scaled up to ₹1,762.39 crore, while purchases of stock-in-trade rose sharply to ₹1,251.70 crore compared to ₹1,025.02 crore in the prior year's first quarter.  

Total consolidated expenses jumped to ₹6,248.25 crore, squeezing profit before tax down to ₹1,081.93 crore from ₹1,769.93 crore in the year-ago period. 

Shareholder Value and Earnings Metrics 

The contraction in profit directly thinned out near-term shareholder financial metrics. Basic earnings per equity share (EPS) for the quarter dropped to ₹9.77 from ₹16.07 reported in the corresponding year-ago quarter.  

Diluted EPS experienced an identical slide, landing at ₹9.76 against ₹16.06 year-on-year. Total comprehensive income attributable to the owners of the parent stood at ₹982.62 crore, contrasting with ₹1,378.82 crore in the corresponding quarter of 2025. 

About Cipla 

Cipla is a prominent Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai. Founded in 1935, it specializes in producing high-quality, affordable generic drugs, APIs, and advanced drug delivery systems for conditions like HIV/AIDS, cancer, and respiratory diseases. 

Cipla Share Price Performance 

As of July 23, 2026, at 12:35 PM, Cipla share price on NSE was trading at ₹1,383.40, down by 2.24% from the previous closing price. 

Conclusion 

Cipla Limited's financial results for the June 2026 quarter reveal a 1.6% YoY increase in total income to ₹7,330.18 crore and a 39.2% YoY decrease in net profit to ₹785.55 crore. The company's annual total income was ₹29,044.60 crore, with a net profit of ₹3,861.74 crore. 

Track the stock market in Hindi. Visit Angel One News for the latest market trends, insights, and share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Take action on today’s market news - Complete your Demat Account Opening now.